Shree Pacetronix

Shree Pacetronix Debt/EBITDA

The Total Debt to EBITDA Ratio of Shree Pacetronix (527005.BO) as of Oct 18, 2026 is 2.19. In the previous year, Total Debt to EBITDA Ratio was 0.74 — a change of 195.91% (higher).

Debt/EBITDA

2.19

YoY

195.91%

Last updated:

Total Debt to EBITDA Ratio of Shree Pacetronix is 2025 2.19 . Total Debt to EBITDA Ratio of Shree Pacetronix was 2024 0.74 . It decreases by 195.91% higher compared to the previous year.

The Shree Pacetronix Debt/EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Debt/EBITDA
Date
Debt/EBITDA
Jan 1, 2016
6.72 INR
Jan 1, 2017
-42.83 INR
Jan 1, 2020
3.30 INR
Jan 1, 2021
3.99 INR
Jan 1, 2022
1.71 INR
Jan 1, 2023
0.40 INR
Jan 1, 2024
0.74 INR
Jan 1, 2025
2.19 INR
The Shree Pacetronix Debt/EBITDA history
YEARDebt/EBITDAYoY
2.19+195.91%
0.74+84.94%
0.40-76.54%
1.71-57.21%
3.99+21.19%
3.30-107.70%
-42.83-737.19%
6.72-39.70%
11.15+317.94%
2.67—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Shree Pacetronix Stock analysis

What does Shree Pacetronix do? Shree Pacetronix Ltd, listed on the Bombay Stock Exchange with ticker 527005.BO and ISIN INE847D01010, is a healthcare company headquartered in Dhar, Madhya Pradesh, India. The company was founded with an IPO on June 8, 1993. It operates within the healthcare sector, specifically in the Life Saving Devices segment. Shree Pacetronix Ltd provides a range of medical devices, including implantable cardiac pacemakers, pacing leads, pacing system analyzers, and physician corners. The company's product portfolio features multi-programmable pacemakers such as Ventralite 940 +/ Tiranga, Pinnacle 8820, and Tiranga 302. Rate responsive pacemakers include Charak DDDR and Pinnacle-R SSIR + Model 297. Bivent pacemakers are represented by the Trinity R model, while external pacemakers include Indus I SSB and Zeus-1. The company also offers a programmer for pacemakers called Smart-E and various pacing leads, including temporary leads, introducer, Screw-in lead P12 Model 3844 VB/3744VB, IS1 Bipolar Lead 3851 VB, and Atrial J Bipolar Lead 3851 VB. The firm's subsidiary is Shree Coratomic Limited. Shree Pacetronix Ltd serves both the Indian market and international regions, operating through its geographical segments of India and the Rest of the World. The company's website is https://www.pacetronix.com/. Shree Pacetronix is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Shree Pacetronix stock

Total Debt to EBITDA Ratio of Shree Pacetronix is 2.19 in 2025.

Total Debt to EBITDA Ratio of Shree Pacetronix changed from 0.74 to 2.19, representing a 195.91% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Total Debt to EBITDA Ratio Shree Pacetronix since 2006 – with annual values, charts, and detailed analysis.

Debt/EBITDA measures total debt relative to earnings before interest, taxes, depreciation, and amortization. It indicates the years needed to repay all debt from EBITDA.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Total Debt to EBITDA Ratio's Shree Pacetronix with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Shree Pacetronix

All Key Metrics — Shree Pacetronix